Follow Forum_Psych on Twitter

Display results as :

Rechercher Advanced Search

We have 222 registered users
The newest registered user is raheelmemon

Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.

Etravirine Shows Fewer Neuropsychiatric AEs Than Efavirenz

View previous topic View next topic Go down

Etravirine Shows Fewer Neuropsychiatric AEs Than Efavirenz

Post  Admin on Wed Jul 20, 2011 7:03 pm

Etravirine Shows Fewer Neuropsychiatric AEs Than Efavirenz

July 20, 2011 (Rome, Italy) — Compared with efavirenz, etravirine appears to be associated with fewer neuropsychiatric adverse events, according to findings from 48 weeks of data from the randomized Study of Efavirenz Neuropsychiatric Events vs Etravirine (SENSE) trial.

Juergen Rockstroh, MD, from the University of Bonn, Medizinische Universitätsklinik, Germany, presented the findings here, during a late-breaking poster session, at the 6th International AIDS Society (IAS) Conference on HIV Pathogenesis, Treatment and Prevention.

Read the complete article at:
Medscape Psych

Click on to post your comments

Posts : 948
Points : 2102
Reputation : 0
Join date : 2011-02-19
Location : Philadelphia

Back to top Go down

View previous topic View next topic Back to top

- Similar topics

Permissions in this forum:
You cannot reply to topics in this forum